Allan Camaisa, CEO and Chairman of the Board at Calidi Biotherapeutics, Inc. (CLDI), sold 10,000 shares at $1.62 ($16K) on 2024-12-17, disclosed to the SEC on 2024-12-18.
Open-market sale of $16k CLDI by CEO and Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.